Atomera Incorporated Reports Third Quarter 2016 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Atomera Incorporated Reports Third Quarter 2016 Results

LOS GATOS, CA--(Marketwired - Nov 8, 2016) - Atomera Incorporated ("Atomera" or the "Company") ( NASDAQ : ATMR ), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today announced financial results for the third quarter ended September 30, 2016.

Management Commentary

"We are very pleased with the progress made during the third quarter on the customer engagement and technology evaluation front with existing potential customers," commented Scott Bibaud, President and CEO. "In addition, the successful completion of our Initial Public Offering and strong cash position, enables us to execute against our business plan. We are starting to see early results in development speed improvement through use of our new specialty fab partner, and increased interest amongst new potential customers," added Mr. Bibaud.

Third Quarter and Year to Date Financial Results

Net loss for the third quarter ended September 30, 2016 was $4.1 million, or $0.55 per basic and diluted share, compared to a net loss of $2.6 million, or $1.61 per basic and diluted share in the second quarter of 2016 and a net loss of $1.35 million in the third quarter of 2015, or $1.09 per basic and diluted share. Net loss for the nine months ended September 30, 2016 was $9.2 million, or $2.58 per basic and diluted share, compared to a net loss in the nine months ended September 30, 2015 of $5.4 million, or $4.37 per basic and diluted share.

Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2016 was a loss of $1.75 million, compared to an adjusted EBITDA loss of $1.80 million in the second quarter and an adjusted EBITDA loss of $751,000 for the third quarter of 2015. Adjusted EBITDA for the nine months ended September 30, 2016 was a loss of $5.4 million compared to an adjusted EBITDA net loss of $3.6 million for the nine months ended September 30, 2015.

Initial Public Offering

On August 10, 2016, we announced the closing of our initial public offering ("IPO") of 3,680,000 shares of common stock at a public offering price of $7.50 per share. The common stock included 480,000 shares sold as a result of the underwriter's exercise in full of its overallotment option. Gross proceeds to us from this offering were $27,600,000 before deducting underwriting discounts, commissions and other offering expenses. In accordance with the terms of the Secured Notes, all principal plus accrued interest through August 10, 2016 (totaling approximately $23.5 million) converted automatically upon consummation of the IPO into 6,264,659 shares of common stock thus extinguishing the debt associated with the Secured Notes.

Ticker Symbol Change

Effective Monday, November 14, 2016, Atomera will change its stock ticker symbol to ATOM.

2016 Third Quarter Conference Call and Webcast

Atomera will host a conference call to discuss its financial results and recent progress. Date : Tuesday, November 8, 2016 Time : 1:30 p.m. PT (4:30 p.m. ET) Phone : 844-263-8318 (domestic); +1 (213) 358-0960 (international) Replay: 855-859-2056 (domestic); +1(404) 537-3406 (international) Call ID: 10221998; until November 15, 2016 Webcast : Accessible at www.atomera.com

Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, taxes, depreciation, amortization, stock-based compensation, the change in fair value of derivative liabilities, and the gain on the extinguishment of debt. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of its reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated has developed Mears Silicon Technology™ ("MST®"), which increases performance and power efficiency in semiconductor transistors. MST® can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.

Safe Harbor

This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST® technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that we have not yet commenced revenue producing operations or entered into a definitive agreement with regard to the licensing or commercialization of our MST technology, thus subjecting us to all of the risks inherent in a pre-revenue enterprise; (2) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST® technology; (3) our ability to protect our proprietary technology, trade secrets and know-how and (4) those other risks disclosed in the section "Risk Factors" included in our final prospectus dated August 5, 2016 filed with the SEC on August 8, 2016. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

   
   
Atomera Incorporated  
Condensed Balance Sheets  
(in thousands)  
   
    September 30,     December 31,  
    2016     2015  
    (Unaudited)        
                 
ASSETS                
                 
Current assets:                
  Cash and cash equivalents   $ 28,189     $ 3,197  
  Restricted investment     -       15  
  Prepaid expenses and other current assets     155       48  
    Total current assets     28,344       3,260  
                 
Property and equipment, net     30       15  
Deferred offering costs     -       145  
Security deposit     37       -  
                 
      Total assets   $ 28,411     $ 3,420  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)                
                 
Current liabilities:                
  Accounts payable   $ 277     $ 301  
  Accrued expenses     106       131  
  Accrued payroll related expenses     95       14  
  Senior secured convertible promissory notes payable, net     -       16,095  
                   
    Total liabilities     478       16,541  
                 
Commitments and contingencies                
                 
Stockholders' equity (deficiency):                
  Preferred stock, $0.001 par value, authorized 2,500 shares; none issued and outstanding at September 30, 2016 and December 31, 2015     -       -  
  Common stock, $0.001 par value, authorized 47,500 shares; 12,025 shares issued and outstanding at September 30, 2016 and 1,617 issued and outstanding as of December 31, 2015     12       2  
  Additional paid-in capital     120,489       70,452  
  Subscription receivable     -       (188 )
  Accumulated deficit     (92,568 )     (83,387 )
    Total stockholders' equity (deficiency)     27,933       (13,121 )
                     
      Total liabilities and stockholders' equity (deficiency)   $ 28,411     $ 3,420  
                 
   
   
Atomera Incorporated  
Condensed Statements of Operations  
(Unaudited)  
(in thousands, except per share amounts)  
   
    Three Months ended September 30,     Nine Months ended September 30,  
    2016     2015     2016     2015  
Operating expenses:                                
  Research and development   $ 940     $ 434     $ 2,753     $ 1,530  
  General and administrative     1,607       342       3,361       2,481  
  Selling and marketing     225       7       435       18  
    Total operating expenses   $ 2,772     $ 783     $ 6,549     $ 4,029  
                                   
      Loss from operations     (2,772 )     (783 )     (6,549 )     (4,029 )
                                 
Other income/(expense):                                
  Interest income     6       2       8       5  
  Interest expense     (1,330 )     (568 )     (2,640 )     (1,363 )
    Total other expense, net     (1,324 )     (566 )     (2,632 )     (1,358 )
                                 
Net loss:   $ (4,096 )   $ (1,349 )   $ (9,181 )   $ (5,387 )
                                 
Net loss per common share, basic and diluted   $ (0.55 )   $ (1.09 )   $ (2.58 )   $ (4.37 )
                                 
Weighted average number of common shares outstanding, basic and diluted     7,382       1,233       3,553       1,233  
                                 
   
   
Atomera Incorporated  
Reconciliation to Non-GAAP Adjusted EBITDA  
(Unaudited)  
(in thousands)  
   
    Three Months ended September 30,     Nine Months ended September 30,  
    2016     2015     2016     2015  
                                 
Net loss (GAAP):   $ (4,096 )   $ (1,349 )   $ (9,181 )   $ (5,387 )
Add (subtract) the following items:                                
    Interest income     (6 )     (2 )     (8 )     (5 )
    Interest expense     1,330       568       2,640       1,363  
    Depreciation and amortization     4       2       10       7  
    Stock-based compensation     1,020       30       1,124       374  
  Adjusted EBITDA (non-GAAP)   $ (1,748 )   $ (751 )   $ (5,415 )   $ (3,648 )
                                 
    Three Months ended June 30,              
    2016     2015              
                                 
Net loss (GAAP):   $ (2,597 )   $ (1,577 )                
Add (subtract) the following items:                                
    Interest income     (2 )     (1 )                
    Interest expense     748       562                  
    Depreciation and amortization     4       2                  
    Stock-based compensation     47       31                  
  Adjusted EBITDA (non-GAAP)   $ (1,800 )   $ (983 )                

Investor Contacts: Frank Laurencio CFO 408.442.5246 Email Contact Nick Kormeluk Investor Relations 949.500.0003 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 61

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
West Virginia Water Gains: Central Grove Upgrade Begins

Updated Category News Views 74

Kickoff at Central Grove: What’s Brewing? Ever wander through Kearneysville, W.Va., and wonder what’s going on with that bustling crew near Goldenrod Drive? The folks at West Virginia American Water have kicked off groundwork for the much-anticipated Central Grove Water Treatment Plant. This, comrades, isn’t just some shiny new shed we’re talking about. Oh no,...

Continue Reading
Delta Dental Expands Free Oral Care Access in NM

Updated Category News Views 107

Bridging Dental Care Gaps in New Mexico When the calendar flips to early November, Delta Dental of New Mexico is joining hands with the NM Mission of Mercy for a no-cost dental clinic at EXPO New Mexico. We're talking doors flying open at 5:15 a.m. sharp, on November 6 and 7. This isn’t some run-of-the-mill thing—they are targeting those who can't easily get or afford...

Continue Reading
Soligenix Holds Steady Amidst Shifting Financial Landscape

Updated Category News Views 47

Stepping into Soligenix's News Every time Soligenix pops up on the radar, it feels like we're watching a biopharma soap opera. This time, they're juggling updates and quarterly numbers that scream both promise and peril. The New Jersey-based company, known for its focus on niche markets with unmet medical needs, tossed out some shiny clinical developments alongside a...

Continue Reading
Yiren Digital's Tumble: Lawsuit Timeline for Investors

Updated Category News Views 59

Yiren's Stock Plunge and the Legal Quagmire What a mess Yiren Digital Ltd. (NYSE:YRD) finds itself in, huh? We're looking at a stunning 44.05% stock nosedive that's left a trail of bruised investors in its wake. Now that's a real gut-punch for any portfolio hugging YRD. So, what's spinning this cycle of chaos for our digital player from across the pond? The Flash Point:...

Continue Reading
CalExitNow Push for CA GOP Ban & Sovereignty Talks

Updated Category News Views 116

California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...

Continue Reading
Lilly's Digital Healthcare Push with Hims & Hers

Updated Category News Views 124

Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...

Continue Reading
Recovery 180's Landmark Facility: Community Impact Unfolds

Updated Category News Views 68

Taneytown Takes a Significant Leap Well, Taneytown's making noise, folks. Never thought this sleepy spot would pull off something so important, but here we are with Recovery 180 opening Taneytown’s first-ever residential Level 3.1 treatment facility. After four years of struggle, the largest venture in Carroll County is opening its doors to residents who desperately...

Continue Reading
Kestrel Group Faces Financial Hit Despite Revenue Growth

Updated Category News Views 97

Kestrel's Financial Rollercoaster Continues Here's the deal with Kestrel Group, folks. They just dropped their Q3 2026 financials, and it's a mixed bag. The top line's looking solid with total revenues hitting $4.8 million, riding high on a 203% jump in Program Services fee income. But dig a little deeper, and there's a $16.4 million net loss staring us in the face....

Continue Reading
ALMIA's Bold Medicare Defense to HHS Committee

Updated Category News Views 67

ALMIA Lays It Out for Medicare Stakeholders The folks at ALMIA are shaking things up, and they're not pulling any punches with the HHS Healthcare Advisory Committee. With this latest move, they've lobbed public comments towards the committee, especially ahead of this intense November 9th meeting. It's part of a larger dialogue kicked off with the Strengthening Medicare...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: Legal Action Against Sable Offshore Corp. Securities

Updated Category News Views 137

Legal Issues Surrounding Sable Offshore Corp. There’s a growing concern among investors regarding Sable Offshore Corp. (NYSE: SOC). The DJS Law Group has taken the initiative to investigate potential violations of securities laws that could impact shareholders significantly. Investors must stay informed to protect their investments amid allegations of misrepresentation...

Continue Reading
FTI Consulting Achieves Robust Earnings Despite Market Challenges

Updated Category News Views 64

FTI Consulting Reports Third Quarter Financial Results FTI Consulting, Inc. (NYSE: FCN) recently announced its financial performance for the third quarter, presenting a noteworthy achievement with earnings of $926 million, marking an increase compared to the previous year. This growth reflects the company's resilience and capacity to adapt amidst fluctuating market...

Continue Reading
Columbus McKinnon Sees Strong Order Growth in Q2 FY25

Updated Category News Views 188

Columbus McKinnon Records Significant Order Growth Columbus McKinnon Corporation (NASDAQ: CMCO) has successfully announced financial performance results reflecting notable progress within the second quarter of its fiscal year 2025. The company, recognized as a leading designer and manufacturer of intelligent motion solutions, achieved a 16% increase in order volume...

Continue Reading
Rhode Island Commerce Celebrates 250 Years of History

Updated Category News Views 309

Rhode Island Commerce Partners with The HISTORY Channel In an exciting initiative commemorating America’s 250th anniversary, Rhode Island Commerce, which serves as the state’s primary economic development agency, has formed a partnership with The HISTORY Channel. This collaboration aims to celebrate Rhode Island's rich heritage as part of the larger project known as...

Continue Reading
Istanbul Market Sees Minor Decline Amidst Select Gains

Updated Category News Views 130

Overview of Istanbul Stock Exchange Performance The recent performance of Turkey's stock market has shown a bit of volatility, particularly noted after the last trading session. As the market closed, several sectors experienced losses, especially in Banking, Sports, and Financials. Despite these challenges, some stocks managed to edge upwards, providing a glimmer of hope...

Continue Reading